Cytokinetics (CYTK) Q2 2022 Earnings

4MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-1.02
-0.8
-0.58
-0.36

Details

Expected EPS
-0.95
Actual EPS
-1.02
Surprise EPS
-0.07
Surprise Percent
+7.37%

Description

Cytokinetics (CYTK) has reported earnings of -1.02 per share for Q2 2022.

0 Comments

Share your thoughts